<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03992651</url>
  </required_header>
  <id_info>
    <org_study_id>EssaiClinique_CTCO</org_study_id>
    <nct_id>NCT03992651</nct_id>
  </id_info>
  <brief_title>Optical Transcutaneous Sensors of Capnia and Oxygenation</brief_title>
  <acronym>CTCO</acronym>
  <official_title>Validation of Optical Transcutaneous Sensors to Measure Capnia and Tissue Oxygenation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at validating new optical transcutaneous sensors to evaluate tissue capnia
      (CO2 partial pressure) and oxygenation (blood oxygen saturation) by comparing them to
      standard laboratory measurements (end tidal CO2 measurements and oxygen saturation by
      near-infrared spectroscopy).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 12, 2019</start_date>
  <completion_date type="Actual">October 11, 2019</completion_date>
  <primary_completion_date type="Actual">June 13, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>One single group will have simultaneous measurements of capnia and tissue oxygenation by the new sensors and by the standard laboratory sensors</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of capnia values</measure>
    <time_frame>Continuous measurement during the only experimental session (1 hour)</time_frame>
    <description>Comparison of capnia values measured by the new sensors and the standard laboratory sensors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of tissue oxygenation values</measure>
    <time_frame>Continuous measurement during the only experimental session (1 hour)</time_frame>
    <description>Comparison of tissue oxygenation values measured by the new sensors and the standard laboratory sensors</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Blood Gas Monitoring, Transcutaneous</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>One single group of healthy subjects</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Measurements of capnia and tissue oxygenation by optical transcutaneous sensors</intervention_name>
    <description>Capnia and tissue oxygenation will be measured by optical transcutaneous sensors</description>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males or females between 18 and 50 year old

          -  Individual having health insurance

          -  Individual able to provided informed consent

        Exclusion Criteria:

          -  Body mass index &gt;27 kg/m²

          -  History of acute mountain sickness

          -  Chronic diseases know to be associated with high methemoglobinemia

          -  Active smoker (&gt;3 cigarets/day)

          -  Alcohol consumption (&gt;10g/day)

          -  Individual with high skin sensitivity due to skin diseases

          -  Mental disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Doutreleau, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Grenoble Alpes Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Grenoble Alpes University Hospital</name>
      <address>
        <city>Grenoble</city>
        <state>Rhône-Alpes</state>
        <zip>38042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>June 17, 2019</study_first_submitted>
  <study_first_submitted_qc>June 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 20, 2019</study_first_posted>
  <last_update_submitted>January 16, 2020</last_update_submitted>
  <last_update_submitted_qc>January 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

